On Sept 9, IHH announced that the discussions between itself, Ramsay and Sime Darby Holdings have concluded and that they did not result in a binding agreement.
CGS-CIMB Research analyst Tay Wee Kuang is still recommending investors “add” their positions into IHH Healthcare Bhd even after discussions in relation to the acquisition of Ramsay Sime Darby Health Care Sdn Bhd were terminated.
Tay has retained his target price of RM8.07 ($2.50).

![IHH has 'plenty [of] opportunities to grow' despite termination of Ramsay Sime-Darby acquisition: CGS-CIMB](https://edgemarkets-transferred.s3-ap-southeast-1.amazonaws.com/styles/article_detail_v2/s3/IHH_1_0.jpeg)